发明名称 Hydroxylamine derivatives useful for enhancing the molecular chaperon production and the preparation thereof
摘要 A method of increasing expression of a molecular chaperon by a cell and/or enhancing the activity of a molecular chaperon in cells is provided. The method comprises treating a cell that is exposed to a physiological stress which induces expression of a molecular chaperon by the cell with an effective amount of a certain hydroxylamine derivative to increase the stress. Alternatively; an hydroxylamine derivative can be administrated to a cell before it is exposed to a physiological stress which induces expression of a molecular chaperon by the cell. Preferably, the cell to which an hydroxylamine derivative is administered is an eukaryotic cell. The hydroxylamine derivative corresponds to the formulae (I) or (II). The invention also provides novel hydroxyl amine derivatives falling within the scope of the formulae (I) and (II) as well as pharmaceutical and/or cosmetical compositions comprising the said compounds.
申请公布号 US6653326(B1) 申请公布日期 2003.11.25
申请号 US19990860582 申请日期 1999.12.07
申请人 BIOREX RESEARCH & DEVELOPMENT CO. 发明人 VIGH LASZLO;NAGY PETER LITERATI;SZILBEREKY JENO;UEROEGDI LASZLO;JEDNAKOVITS ANDREA;JASZLITS LASZLO;BIRO KATALIN;MARVANYOS EDE;BARABAS MIHALY;HEGEDUES ERZSEBET;KORANYI LASZLO;KUERTHY MARIA;BALOGH GABOR;HORVATH IBOLYA;TOEROEK ZSOLT;UDVARDY EVA;DORMAN GYOERGY;MEDZIHRADSZKY DENES;MEZES BEA;KOVACS ESZTER;DUDA ERNOE;FARKAS BEATRIX;GLATZ ATTILA
分类号 A61K31/15;A61K;A61K31/133;A61K31/34;A61K31/341;A61K31/44;A61K31/443;A61K31/4433;A61K31/445;A61K31/47;A61K31/472;A61K31/495;A61K31/496;A61P9/00;A61P9/08;A61P9/10;A61P25/00;A61P25/18;A61P25/28;A61P31/12;A61P35/00;A61P37/00;A61P37/08;C07C;C07C215/00;C07C259/02;C07C259/18;C07C275/64;C07C279/18;C07D;C07D213/78;C07D213/81;C07D213/89;C07D215/16;C07D215/54;C07D217/22;C07D217/26;C07D271/06;C07D295/08;C07D295/088;C07D295/22;C07D307/68;C07D333/38;C07D405/12;C07D409/12;C07D413/04;C12N5/04;C12N5/06;C12N15/67;C12P21/00;C12R1/91;(IPC1-7):H61K31/44 主分类号 A61K31/15
代理机构 代理人
主权项
地址